epinastine has been researched along with Edema in 3 studies
epinastine: RN given refers parent cpd
epinastine : A benzazepine that is 6,11-dihydro-5H-dibenzo[b,e]azepine in which the azepine ring is fused to the e side of 4,5-dihydro-1H-imidazol-2-amine.
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to compare the clinical efficacy and ocular surface variables of olopatadine, ketotifen fumarate, epinastine, emedastine and fluorometholone acetate ophthalmic solutions in preventing the signs and symptoms of seasonal allergic conjunctivitis (SAC)." | 9.14 | Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. ( Akman, A; Akova, YA; Borazan, M; Erbek, SS; Karalezli, A; Kiyici, H, 2009) |
| "The inhibitory effect of epinastine (WAL 801 CL, CAS 80012-43-7) on types II, III and IV allergic reactions was studied." | 7.68 | Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs. ( Adachi, Y; Izushi, K; Kamei, C; Shimazawa, M; Tasaka, K, 1991) |
| "We aimed to compare the clinical efficacy and ocular surface variables of olopatadine, ketotifen fumarate, epinastine, emedastine and fluorometholone acetate ophthalmic solutions in preventing the signs and symptoms of seasonal allergic conjunctivitis (SAC)." | 5.14 | Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial. ( Akman, A; Akova, YA; Borazan, M; Erbek, SS; Karalezli, A; Kiyici, H, 2009) |
| "The inhibitory effect of epinastine (WAL 801 CL, CAS 80012-43-7) on types II, III and IV allergic reactions was studied." | 3.68 | Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs. ( Adachi, Y; Izushi, K; Kamei, C; Shimazawa, M; Tasaka, K, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borazan, M | 1 |
| Karalezli, A | 1 |
| Akova, YA | 1 |
| Akman, A | 1 |
| Kiyici, H | 1 |
| Erbek, SS | 1 |
| Inagaki, N | 1 |
| Nagao, M | 1 |
| Nakamura, N | 1 |
| Kawasaki, H | 1 |
| Igeta, K | 1 |
| Musoh, K | 1 |
| Nagai, H | 1 |
| Kamei, C | 1 |
| Izushi, K | 1 |
| Adachi, Y | 1 |
| Shimazawa, M | 1 |
| Tasaka, K | 1 |
1 trial available for epinastine and Edema
| Article | Year |
|---|---|
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Child; Conjunctival Diseases; Conjunctiviti | 2009 |
2 other studies available for epinastine and Edema
| Article | Year |
|---|---|
Evaluation of anti-scratch properties of oxatomide and epinastine in mice.
Topics: Animals; Anti-Allergic Agents; Antipruritics; Capillary Permeability; Dibenzazepines; Dinitrofluorob | 2000 |
Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
Topics: Animals; Arthus Reaction; Dexamethasone; Dibenzazepines; Edema; Erythrocytes; Forssman Antigen; Guin | 1991 |